Lujia Dong

979 total citations
34 papers, 748 citations indexed

About

Lujia Dong is a scholar working on Oncology, Hematology and Epidemiology. According to data from OpenAlex, Lujia Dong has authored 34 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Hematology and 9 papers in Epidemiology. Recurrent topics in Lujia Dong's work include CAR-T cell therapy research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Cytomegalovirus and herpesvirus research (7 papers). Lujia Dong is often cited by papers focused on CAR-T cell therapy research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Cytomegalovirus and herpesvirus research (7 papers). Lujia Dong collaborates with scholars based in China, United States and Japan. Lujia Dong's co-authors include Tong Wu, Dao‐Pei Lu, Huan Chen, Xiao‐Jun Huang, Dao-Pei Lu, Mei-Jie Zhang, Kai-Yan Liu, Wei Han, Dan Li and Yu-Hong Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cellular Signalling.

In The Last Decade

Lujia Dong

32 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lujia Dong China 10 428 340 239 125 121 34 748
Nancy M. Hardy United States 15 374 0.9× 426 1.3× 224 0.9× 42 0.3× 114 0.9× 63 784
Abhinav Deol United States 18 631 1.5× 582 1.7× 281 1.2× 81 0.6× 119 1.0× 114 1.1k
Mary Sartor Australia 14 348 0.8× 184 0.5× 262 1.1× 241 1.9× 137 1.1× 36 737
Jennifer A. Kanakry United States 14 196 0.5× 532 1.6× 195 0.8× 124 1.0× 45 0.4× 51 769
Sridhar Chaganti United Kingdom 18 138 0.3× 617 1.8× 235 1.0× 135 1.1× 88 0.7× 61 944
Xiang‐Yu Zhao China 17 390 0.9× 278 0.8× 398 1.7× 189 1.5× 83 0.7× 69 747
Jonathan E. Brammer United States 16 210 0.5× 423 1.2× 295 1.2× 55 0.4× 98 0.8× 112 888
Michael W. Boyer United States 14 299 0.7× 282 0.8× 304 1.3× 25 0.2× 66 0.5× 29 700
Kitsada Wudhikarn Thailand 14 162 0.4× 541 1.6× 144 0.6× 49 0.4× 57 0.5× 55 742
Don A. Stevens United States 15 223 0.5× 469 1.4× 146 0.6× 80 0.6× 44 0.4× 100 798

Countries citing papers authored by Lujia Dong

Since Specialization
Citations

This map shows the geographic impact of Lujia Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lujia Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lujia Dong more than expected).

Fields of papers citing papers by Lujia Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lujia Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lujia Dong. The network helps show where Lujia Dong may publish in the future.

Co-authorship network of co-authors of Lujia Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Lujia Dong. A scholar is included among the top collaborators of Lujia Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lujia Dong. Lujia Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xiaoming, Lujia Dong, Pengfei Yuan, et al.. (2024). Contribution of PKS+ Escherichia coli to colon carcinogenesis through the inhibition of exosomal miR-885-5p. Heliyon. 10(18). e37346–e37346.
2.
Dong, Lujia, et al.. (2022). LncRNA ARST is a Novel Prognostic and Diagnostic Biomarker for Colorectal Cancer. SHILAP Revista de lepidopterología. 6 indexed citations
3.
Wang, Jianguang, et al.. (2020). LncRNA NR2F1-AS1 Regulates miR-371a-3p/TOB1 Axis to Suppress Proliferation of Colorectal Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 35(10). 760–764. 20 indexed citations
4.
Yang, Lihua, Xiaoli Ma, Yuchen Liu, et al.. (2017). Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China. Blood. 130. 3335–3335. 15 indexed citations
7.
Dong, Lujia, et al.. (2016). Haploidentical hematopoietic stem cell transplantation for a case with X‐linked chronic granulomatous disease. Pediatric Transplantation. 21(1). 8 indexed citations
10.
Dong, Lujia, Tong Wu, Mei-Jie Zhang, et al.. (2010). The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation in Hematologic Malignancies Are Not Associated with Patient Age. Biology of Blood and Marrow Transplantation. 17(8). 1205–1213. 5 indexed citations
11.
Dong, Lujia, Zhiyong Gao, Lung‐Ji Chang, et al.. (2009). Adoptive Transfer of Cytomegalovirus/Epstein-Barr Virus-specific Immune Effector Cells for Therapeutic and Preventive/Preemptive Treatment of Pediatric Allogeneic Cell Transplant Recipients. Journal of Pediatric Hematology/Oncology. 32(1). e31–e37. 26 indexed citations
12.
Dong, Lujia, Tong Wu, Mei‐Jie Zhang, Zhiyong Gao, & Dao‐Pei Lu. (2007). CD3+ Cell Dose and Disease Status Are Important Factors Determining Clinical Outcomes in Patients Undergoing Unmanipulated Haploidentical Blood and Marrow Transplantation after Conditioning Including Antithymocyte Globulin. Biology of Blood and Marrow Transplantation. 13(12). 1515–1524. 28 indexed citations
13.
Wang, Liru, Lujia Dong, Mei‐Jie Zhang, & Dao‐Pei Lu. (2006). The Impact of Human Herpesvirus 6B Reactivation on Early Complications following Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 12(10). 1031–1037. 41 indexed citations
14.
Wang, Liru, Lujia Dong, & Dao‐Pei Lu. (2006). Surveillance of Active Human Herpesvirus 6 Infection in Chinese Patients after Hematopoietic Stem Cell Transplantation with 3 Different Methods. International Journal of Hematology. 84(3). 262–267. 9 indexed citations
15.
Wang, Liru, Lujia Dong, & Dao‐Pei Lu. (2006). [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].. PubMed. 14(6). 1204–9. 2 indexed citations
16.
Chen, Yao, Dao‐Pei Lu, Kai‐Yan Liu, et al.. (2005). [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].. PubMed. 26(2). 74–7. 1 indexed citations
18.
Sun, Yi, Lujia Dong, Shengqi Wang, et al.. (2004). [Identification of acute leukemia-specific genes from leukemia recipient/sibling donor pairs by distinguishing study with oligonucleotide microarrays].. PubMed. 12(4). 450–4. 6 indexed citations
19.
Wang, Li, Lujia Dong, Fang Tian, Guangxian Liu, & Chunhai Li. (2003). Aberrant expression and deletion of FHIT gene in leukemias.. PubMed. 11(2). 153–60. 3 indexed citations
20.
Dong, Lujia, et al.. (1999). Transcripts of Immunoglobulin Germline Mu: An Amplified Myeloid and B-Lymphoid Common Gene Program in Various Leukemias. Acta Haematologica. 101(3). 119–123. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026